Systemic barriers beyond just the price of drugs can impact health care costs, emphasizing the need for comprehensive ...

HHS budget slashes National Institutes of Health (NIH) funding by 40%, alarming health experts and threatening vital research ...

Medicare Part B drug negotiations in 2028 pose challenges for providers, requiring new payment systems and strategies to ...

Global type 1 diabetes cases are on the rise, especially in low-income countries, highlighting an urgent need for targeted ...

Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with ...

Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP), shares updates ...

Innovative therapies for ovarian cancer, including engineered T cells and antibody-drug conjugates, show promise in improving ...

Implementing LGBTQ+ inclusive language in patient care and clinical trials for dermatology could improve data accuracy, ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in ...

With potential lung cancer nodules sometimes slipping through the cracks, educating stakeholders about artificial ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in ...

Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...